| |
Group-A(Elderly) |
Group-B(Young) |
P value |
| Baseline Compliance |
20(40%) |
35(70%) |
0.0003 |
| Reasons for non compliance |
| Cost |
6(20%) |
4(26.7%) |
NS |
| Cost & Poor Memory |
7(23.3%) |
0 |
0.001 |
| Poor Memory |
11(36.7%) |
0 |
0.001 |
| Relief of Symptoms |
6(20%) |
11(73.3%) |
NS |
| Baseline use of Inhalational therapy |
23(46%) |
33(66%) |
0.044 |
| Technique of Inhalation |
| Confident and Demonstrate Correctly |
7(30.4%) |
19(57.6%) |
0.045 |
| Confident but does not Demonstrate Correctly |
14(60.9%) |
12(36.4%) |
NS |
| Neither Confident Nor Demonstrate Correctly |
2(8.7%) |
2(6%) |
NS |
| Number of comorbidities |
| 0 |
1(2%) |
31(62%) |
0.0001 |
| 1 |
12(24%) |
11(22%) |
NS |
| 2 |
9(18%) |
5(10%) |
NS |
| 3 |
11(22%) |
2(4%) |
0.007 |
| ≥ 4 |
17(34%) |
1(2%) |
0.0001 |
| Type |
| Gastro Esophageal Reflux Disease |
33(66%) |
18(36%) |
0.0027 |
| Hypertension |
28(56%) |
5(10%) |
0.0001 |
| Visual Impairment |
27(54%) |
4(8%) |
0.0001 |
| Depressive Symptoms |
26(52%) |
4(8%) |
0.0001 |
| Osteoartiritis |
20(40%) |
0 |
0.0001 |
| Hearing Impairment |
2(4%) |
0 |
NS |
| Benign Hypertrophy Prostate |
6(12%) |
0 |
0.027 |
| Senile Dementia |
5(10%) |
0 |
NS |
| Diabetes Mellitus |
3(6%) |
2(4%) |
NS |
| Other drug use |
| 0 |
16(32%) |
30(60%) |
0.039 |
| 1 |
7(14%) |
10(20%) |
NS |
| 2 |
5(10%) |
5(10%) |
NS |
| 3 |
8(16%) |
4(8%) |
NS |
| ≥ 4 |
14(28%) |
1(2%) |
0.001 |
| Presence of confidante |
40(80%) |
48(96%) |
0.01 |
| Frequency of contact with confidante |
| Daily |
17(34%) |
40(80%) |
0.002 |
| Weekly |
9(18%) |
6(12%) |
NS |
| < monthly |
4(8%) |
1(2%) |
NS |
| Monthly |
10(20%) |
1(2%) |
0.007 |
| No Contact |
10(20%) |
2(4%) |
0.021 |
| Impaired Quality of Life |
27(54%) |
7(14%) |
0.001 |
| Depressive Symptoms |
26(52%) |
4(8%) |
0.001 |
| Fatigue |
33(66%) |
18(36%) |
0.003 |
| Impaired Social Functioning |
24(48%) |
13(26%) |
0.023 |
